Please provide your email address to receive an email when new articles are posted on . The estimated added effect of provocation was not significant for either condition. The findings have ...
BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain ...
The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major depressive ...
This life-changing Health Canada-approved technology directly targets the brain circuits involved in OCD—without the side effects of medication. Patients tell us they feel like they’re finally getting ...
Nearly one in four American adults lives with a mental health condition. That’s more than 60 million people — veterans, teenagers, working parents, executives — navigating depression, anxiety, OCD and ...
Alta Health offers TMS therapy in Dallas, TX, providing evidence-based, non-invasive treatment for adults with ...
BURLINGTON, Mass. and JERUSALEM, Oct. 11, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
High-frequency deep transcranial magnetic stimulation (dTMS) may offer new hope for patients with treatment-resistant obsessive-compulsive disorder (OCD), new research suggests. Results of a 6-week, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results